Apellis Pharmaceuticals Inc (APLS) Insider Trading
- $23,844,337.28
- $104,494,428.96
- Jan. 17, 2025
- Alec Machiels
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 11, 2019 | Major Shareholder | 441,176 | $17.00 | Buy | $7,499,992.00 | |
| Sept. 21, 2018 | Major Shareholder | 81,323 | $19.48 | Buy | $1,584,172.04 | |
| Sept. 19, 2018 | Major Shareholder | 140,000 | $18.34 | Buy | $2,567,600.00 | |
| Sept. 14, 2018 | General Counsel | 15,776 | $18.78 | Sell | $296,273.28 | |
| May 24, 2018 | Insider | 2,935 | $20.37 | Buy | $59,785.95 | |
| Nov. 13, 2017 | Major Shareholder | 127,515 | $14.00 | Buy | $1,785,210.00 |
Insiders are both buying and selling Apellis Pharmaceuticals Inc stock.
The insider traders at Apellis Pharmaceuticals Inc are: Alec Machiels, Cedric Francois, Federico Grossi, Pascal Deschatelets, A. Sinclair Dunlop, David O Watson, Mark Jeffrey Delong, Timothy Eugene Sullivan, Adam J Townsend, Lukas Scheibler, James George Chopas, Jeffrey Eisele, Nicole D Perry, Morningside Venture Investment, Nur Nicholson, Karen Lewis, Caroline Baumal, Machiels Alec, Global Strategic Fund I Venbio, Deschatelets Pascal, Victoria L Brown, and Victoria L. Brown
The most active insider trader at Apellis Pharmaceuticals Inc is Alec Machiels with 30 trades.
Cedric Francois has sold the most Apellis Pharmaceuticals Inc stock with a total value of $35,227,865.41.
Morningside Venture Investment has bought the most Apellis Pharmaceuticals Inc stock with a total value of $31,651,764.04.
The most recent insider trade for Apellis Pharmaceuticals Inc was on Jan. 17, 2025.
The single biggest insider buy for Apellis Pharmaceuticals Inc was from Morningside Venture Investment with a total value of $10,000,000.00 on Nov. 18, 2021.
The single biggest insider sell for Apellis Pharmaceuticals Inc was from Cedric Francois with a total value of $16,027,500.00 on March 1, 2024.